Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
ICON
NasdaqGS:ICLR Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
ICON
Popular
Undervalued
Overvalued
ICON
WA
Analyst Price Target
Consensus Narrative from 17 Analysts
New Pharma Partnerships And Tech Automation Will Drive Future Market Share
Key Takeaways Strategic partnerships and award opportunities in new therapeutic areas are expected to drive revenue growth and increase market share. Cost management, improved processes, and technology leverage could enhance operational efficiency and positively impact earnings and shareholder value.
View narrative
US$259.00
FV
22.2% undervalued
intrinsic discount
4.13%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
ICLR
ICON
Your Fair Value
US$
Current Price
US$201.39
3.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
10b
2015
2018
2021
2024
2025
2027
2030
Revenue US$10.4b
Earnings US$995.3m
Advanced
Set as Fair Value